Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark.
Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
J Psychopharmacol. 2022 Apr;36(4):470-478. doi: 10.1177/02698811221080465.
Benzodiazepines, Z-drugs, pregabalin, and melatonin (BZPMs) have been associated with a higher risk of traffic accidents, but the evidence is inconsistent, and lacking for newer drugs.
To examine the association of BZPMs with risk of traffic accidents.
All Danish adults ( = 3,823,588) were followed for redeemed prescriptions of BZPM and for incident traffic accidents registered in Danish registers from 2002 through 2018. Associations were examined in cohort and case-crossover designs using Cox proportional hazard and conditional logistic regression with adjustment for co-variables.
A total of 19.3% ( = 738,019) of all participants initiated treatment with BZPMs. During the mean follow-up of 10.3 years, 595,173(15.5%) of participants were involved in a traffic accident. In the cohort analysis, all BZPMs besides pregabalin were associated with a higher risk of traffic accidents in adults below 70 years, with chlordiazepoxide showing the strongest association (hazard ratio (HR) = 1.76, 95% confidence interval (CI): 1.67-1.86 and HR = 1.84, 95% CI: 1.70-2.00). In the older age groups, the specific BZPM medications were associated with lower or no risk of traffic accidents. However, in case-time-crossover analysis with inherited control for confounders, no BZPM medication was positively associated with traffic accidents, except for chlordiazepoxide, which had a higher odds ratio in middle-aged group (1.62, 95% CI: 1.15-2.29).
This study does not fully support that BZPM use is a risk factor for traffic accidents. However, a positive association was found for chlordiazepoxide, which is approved for treatment of acute alcohol withdrawal.
苯二氮䓬类药物、Z 类药物、普瑞巴林和褪黑素(BZPMs)与交通事故风险增加有关,但证据不一致,且缺乏对新型药物的研究。
研究 BZPMs 与交通事故风险的相关性。
对 2002 年至 2018 年期间丹麦所有成年人( = 3823588 人)使用 BZPM 的处方和丹麦登记处记录的交通事故事件进行随访。使用 Cox 比例风险和条件逻辑回归,调整协变量,分别在队列和病例交叉设计中检查关联。
共有 19.3%( = 738019 人)的参与者开始使用 BZPMs 治疗。在平均 10.3 年的随访期间,有 595173(15.5%)名参与者发生交通事故。在队列分析中,除普瑞巴林外,所有 BZPMs 在 70 岁以下成年人中与交通事故风险增加相关,其中氯氮䓬的相关性最强(风险比(HR) = 1.76,95%置信区间(CI):1.67-1.86 和 HR = 1.84,95% CI:1.70-2.00)。在年龄较大的组中,特定的 BZPM 药物与较低或无交通事故风险相关。然而,在病例时间交叉分析中,考虑了混杂因素的遗传控制,除氯氮䓬外,没有一种 BZPM 药物与交通事故呈正相关,氯氮䓬在中年组的比值比更高(1.62,95% CI:1.15-2.29)。
本研究不完全支持 BZPM 使用是交通事故的危险因素。然而,对于氯氮䓬,我们发现了一个阳性关联,氯氮䓬被批准用于治疗急性酒精戒断。